Client News

Galimedix Therapeutics Initiates Pivotal Phase 2 Study with GAL-101 Eye Drops in Dry AMD

InflaRx Announces First Patient Dosed in Phase 2a Study for Oral C5aR Inhibitor INF904

Mainz Biomed Forms Agreement with Quest Diagnostics to Provide Clinical Trials Laboratory Services for Colorectal Cancer Screening Test

iOmx Therapeutics Submits Clinical Trial Application for IOMX-0675

CARBIOS Postpones Construction of its Longlaville PET Biorecycling Plant for 6 to 9 Months, Considering Delayed Non-Dilutive Sources of Financing, and Confirms Major Advances in Commercial Contract Negotiations

ViGeneron Announces FDA Clearance of IND for Novel mRNA Trans-Splicing Gene Therapy VG801 to Treat Stargardt Disease and Other ABCA4-Linked Retinal Dystrophies

invIOs to Present Progress Across Oncology Pipeline During JP Morgan Week 2025

Medigene AG Submits Clinical Trial Application in Europe for MDG1015 for Multiple Solid Tumor Indications

Nyxoah Announces Commercial Launch of Genio® Innovative Therapy in England

Newron and EA Pharma (a Subsidiary of Eisai Co., Ltd.) Announce License Agreement for Evenamide in Japan and Other Asian Territories